Pharmaceutical Stocks Dive as Top FDA Vaccine Regulator Departs
Moderna (MRNA) is another interesting choice today. MRNA stock has dropped 11.66% alongside the FDA news, the largest of the listed drug companies. While Moderna has a consensus Hold rating, this fall leaves it with a potential 50.80% upside.
Drugmaker shares sink after key FDA official ousted
Shares of U.S. drugmakers fell after reports that the Food and Drug Administration's top vaccine official had been forced to resign. The ouster of Dr. Peter Marks played a key role in developing COVID-19 vaccines during President Trump's first term.
Telomir Pharmaceuticals, Inc.’s TELO share price has dipped by 17.60%, which has investors questioning if this is right time ...
Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks’s resignation in protest of Robert ...
All three companies are early-stage biotechnology companies working on next-generation therapeutics with advanced ...
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 11.27%, which has investors questioning if this is right time to buy.
As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and ...
Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
Swiss National Bank increased its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 34.4% during the 4th ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback